This brand name is authorized in Austria
The drug IROCOPHAN contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Carbasalate calcium
UNII N667F17JP1 - CARBASPIRIN CALCIUM
|
|
Carbasalate calcium is a complex of calcium acetyl salicylic acid and urea. It is a thrombocyte aggregation inhibitor. The antithrombotic effect is due to the irreversible acetylating of the enzyme cyclo-oxygenase in the thrombocyte, through which the formation of the prostaglandin thromboxane A2 is inhibited. |
|
2
Paracetamol
UNII 362O9ITL9D - ACETAMINOPHEN
|
|
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
|
3
Caffeine
UNII 3G6A5W338E - CAFFEINE
|
|
Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N02BE51 | Paracetamol, combinations excl. psycholeptics | N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BE Anilides |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
